Close Menu
Business Voice NowBusiness Voice Now
    Facebook X (Twitter) Instagram
    Business Voice NowBusiness Voice Now
    Subscribe
    • Markets
      • BFSI
      • Capital Goods
    • Business
      • FMCG
      • Retail
      • Quick Commerce
      • Startups
    • Healthcare
    • Technology
    • Auto
    • Real Estate
    • Energy
    • Voices
      • Entrepreneur – CXO Stories
      • Corporate Office story
    • E Magazine
      • Year 2026
        • July 2026
    Business Voice NowBusiness Voice Now
    Home»Business»Dr. Ajit Kamath, Managing Director Of Arch Pharmalabs Ltd Conferred Honorary Doctorate in Health Administration by Indian Institute of Technical Research and Business Studies
    Business

    Dr. Ajit Kamath, Managing Director Of Arch Pharmalabs Ltd Conferred Honorary Doctorate in Health Administration by Indian Institute of Technical Research and Business Studies

    By February 2, 2022No Comments2 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Email
    Follow Us
    Google News Flipboard Threads
    Share
    Facebook Twitter LinkedIn Pinterest Email

    New Delhi (India), February 02: Dr. Ajit Kamath, Promoter and Managing Director of Arch Pharmalabs Ltd, was conferred “Honorary Doctorate in Health Administration by prestigious University The Indian Institute of Technical Research and Business Studies For his exemplary contribution of over 25 years in the field of Pharmaceuticals in a virtual ceremony commemorating  73 Years of the Republic of India.

    Arch Pharmalabs Ltd. is a Mumbai Headquartered company based in India. Arch has multiple USFDA approved facilities with multiple chemistry capabilities from kilogram to multi-ton scale. Arch has been at the forefront of attracting and practising path-breaking technologies in the field of manufacturing of Active Pharmaceutical Ingredients and Intermediates. Arch has been manufacturing, commercially, various import substitutes and complex intermediates covering, but not limited to, blockbuster drugs like Atorvastatin, Rosuvastatin, Ursodeoxycholic Acid etc.

    Recently it has also diversified into Lithium compounds.

    For over two and a half decades, Dr. Ajit Kamath has had extensive top-level decision-making and risk-taking experience in Arch Pharmalabs Limited’s dynamic global business. Accepting the degree, Dr.  Ajit Kamath said, “I am extremely honoured to receive this Honorary Doctorate from a University that plays such an important role in developing the potential and talent of tens of thousands of students from all over the world. May you all be fortunate enough to know someone who will inspire you to feel the joy and satisfaction that comes from helping others.”

    For more information, please visit http://www.archpharmalabs.com/

    Business
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    Shyam Rungta of Regain Energies Solutions Pvt. Ltd. On Building India’s Solar PV Recycling Ecosystem

    July 16, 2026

    Sotefin Bharat Limited IPO Opens on Thursday, July 16, 2026

    July 16, 2026

    Gujarat Inject (Kerala) Limited’s revenue, profit zoom in Q1 of FY2027

    July 16, 2026

    Comments are closed.

    Recent Post
    • World’s First Spiritual Wellness City Planned on Maharashtra-Goa Border
    • Dr.Jay Singh Nayak’s Journey from Adversity to a ₹500 Crore Real Estate Enterprise Inspires a New Generation of Entrepreneurs
    • From Literacy to Prosperity: Education’s Impact on India’s GDP
    • Shyam Rungta of Regain Energies Solutions Pvt. Ltd. On Building India’s Solar PV Recycling Ecosystem
    • Sotefin Bharat Limited IPO Opens on Thursday, July 16, 2026
    • XLRI’s XCITE Opens Applications for Its First Rural Business Incubation Cohort
    • Gujarat Inject (Kerala) Limited’s revenue, profit zoom in Q1 of FY2027
    • Ahead of MILT Congress 2026, Global Industry Leaders Reveal the Trends Reshaping MICE and Luxury Travel

    Type above and press Enter to search. Press Esc to cancel.